|
Market Closed -
Hong Kong S.E.
12:08:55 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 19.28 HKD | -1.68% |
|
-2.03% | -41.22% |
| 08-27 | VISEN Pharmaceuticals Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-27 | VISEN Pharmaceuticals Announces Board and Committee Changes | CI |
Company Valuation: VISEN Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,095 | 1,798 | - | - |
| Change | - | -41.91% | - | - |
| Enterprise Value (EV) 1 | 2,640 | 1,536 | 1,799 | 1,938 |
| Change | - | -41.82% | 17.11% | 7.76% |
| P/E | -12.1x | - | - | - |
| PBR | 4.22x | 3.61x | 7.27x | 16.8x |
| PEG | -0.5x | - | - | - |
| Capitalization / Revenue | 18,761x | 26.5x | 5.62x | 2.09x |
| EV / Revenue | 15,999x | 22.7x | 5.62x | 2.25x |
| EV / EBITDA | -12.1x | -6.36x | -6.86x | -11.8x |
| EV / EBIT | -12.7x | -6.25x | -6.81x | -11.7x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -2.44 | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 0.165 | 67.73 | 319.8 | 860.8 |
| EBITDA 1 | -218 | -241.4 | -262.4 | -164.1 |
| EBIT 1 | -208.6 | -245.7 | -264.3 | -166.2 |
| Net income | -253.4 | - | - | - |
| Net Debt 1 | -455.7 | -262.3 | 0.4861 | 140.2 |
| Reference price 2 | 29.47 | 16.49 | 16.49 | 16.49 |
| Nbr of stocks (in thousands) | 105,021 | 109,035 | - | - |
| Announcement Date | 12/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 22.68x | -6.36x | -.--% | 268M | |
| 31.04x | 5.6x | 16.76x | 1.05% | 45.48B | |
| -20.85x | 240.83x | -22.36x | -.--% | 43.68B | |
| 33.71x | 3.27x | 14.1x | -.--% | 43.09B | |
| 45.39x | 5.23x | 28.64x | -.--% | 39.4B | |
| 27.03x | 8.15x | 20.66x | 0.42% | 31.91B | |
| 33.41x | 5.47x | 24.85x | -.--% | 16.4B | |
| 23.57x | 2.06x | 8.94x | 1.13% | 14.24B | |
| 74.44x | 3.94x | 15.27x | -.--% | 13.28B | |
| Average | 30.97x | 33.03x | 11.17x | 0.29% | 27.53B | |
| Weighted average by Cap. | 26.17x | 46.65x | 11.77x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2561 Stock
- Valuation VISEN Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
